Charles Bruce Kemmler, MD, PhD

Emergency Medicine
Accepting new patients
Sees patients age 18 and up
Penn Emergency Medicine Penn Presbyterian
View 1 additional location
Call 215-662-8000
Headshot of Charles Bruce Kemmler, MD, PhD
Penn Medicine Provider

About me

  • Assistant Professor of Clinical Emergency Medicine

My education and training

  • Medical School: University of Colorado at Denver
  • Residency: University of Pennsylvania Health System

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Kemmler is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Jackson, E.M. and C.B. Kemmler Young Man with Right Flank and Leg Swelling , Annals of Emergency Medicine, 83(5): 2024,490-491

Kemmler CB, Sangal RB, Rothenberg C, Li SX, Shofer FS, Abella BS, Venkatesh AK, Foster SD Delays in antibiotic redosing: Association with inpatient mortality and risk factors for delay , Am J Emerg Med. , 46: 2021,63-69

Kemmler C.B., Saleem, S.G., Ali, S., Samad, L., Haider, K.F., Jamal, M.I., Aziz, T., Maroof, Q., Dadabhoy, F.Z., Yasin, Z., Rybarczyk, M.M. A 1-year training program in emergency medicine for physicians in Karachi, Pakistan: Evaluation of learner and program outcomes , AEM Educ Train, 5(3): 2021,e10625

King TH, Kemmler CB, Guo Z, Mann D, Lu Y, Coeshott C, Gehring AJ, Bertoletti A, Ho ZZ, Delaney W, Gaggar A, Subramanian GM, McHutchison JG, Shrivastava S, Lee YJ, Kottilil S, Bellgrau D, Rodell T and D. Apelian A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance , PLoS One, 9(7): 2014,e101904

Buhrman JD, Jordan KR, U’Ren L, Sprague J, Kemmler CB, and Slansky JE Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigens , Cancer Research, 73(1): 2013,74-85

Kemmler CB, Clambey ET, Kedl RM, Slansky JE Elevated tumor-association antigen expression suppresses variant peptide vaccine responses , J. Immunol, 187(9): 2011,4431-9

Jordan KR, McMahan RH, Kemmler CB, Kappler JW, Slansky JE Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens , Natl. Acad. Sci., 107(10): 2010,4652-7

McWilliams JA, Sullivan RT, Jordan KR, McMahan RH, Kemmler CB, McDuffie M, Slansky JE Age-dependent tolerance to an endogenous tumor-associated antigen , Vaccine, 26: 2008,1863-73

Haller AA, Lauer GM, King TH, Kemmler CB, Fiolkoski V, Lu Y, Bellgrau D, Rodell, TC, Apelian D, Franzusoff A, Duke RC Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins , Vaccine, 25(8): 2007,1452-63